Omotayo Ashafa

Dr. Omotayo Ashafa


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SSSaheed Sabiu
Saheed Sabiu
FOF.H. O’neill
F.H. O’neill
OAOmotayo Ashafa
Omotayo Ashafa

26 November 2018 in Planta Medica
Verified
Journal Article
Closed access
PDF file
FBFatai Oladunni Balogun
Fatai Oladunni Balogun
OAOmotayo Ashafa
Omotayo Ashafa
South Africa contains 9% of the worldʼs higher plants, and despite its rich biodiversity, it has one of the highest prevalence of hypertension in Africa. This review provides information on medicinal plants embraced in South Africa for hypertension management, with the aim of reporting pharmacological information on the indigenous use of these plants as antihypertensives. This review not only focuses on the activity of antihypertensive medicinal plants but also reports some of its phytochemical constituents and other ethnopharmacological and therapeutic properties. Information obtained from scientific and or unpublished databases such as Science Direct, PubMed, SciFinder, JSTOR, Google Scholar, Web of Science, and various books revealed 117 documented antihypertensive plant species from 50 families. Interestingly, Asteraceae topped the list with 16 species, followed by Fabaceae with 8 species; however, only 25% of all plant species have demonstrated antihypertensive effects originating from both in vitro and in vivo studies, lending credence to their folkloric use. Only 11 plant species reportedly possess antihypertensive properties in animal models, with very few species subjected to analytical processes to reveal the identity of their bioactive antihypertensive compounds. In this review, we hope to encourage researchers and global research institutions (universities, agricultural research councils, and medical research councils), particularly those showing an interest in natural products, for the need for concerted efforts to undertake more studies aimed at revealing the untapped potential of these plants. These studies are very important for the development of new pharmaceuticals of natural origin useful for the management of hypertension.

29 June 2016 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
Fatai Oladunni BalogunFatai Oladunni Balogun
Fatai Oladunni Balogun
NTNatu Thomas Tshabalala
Natu Thomas Tshabalala
OAOmotayo Ashafa
Omotayo Ashafa
Diabetes mellitus (DM) belongs to the group of five leading important diseases causing death globally and remains a major health problem in Africa. A number of factors such as poverty, poor eating habit, and hormonal imbalance are responsible for the occurrence of the disease. It poses a major health challenge in Africa continent today and the prevalence continues to increase at an alarming rate. Various treatment options particularly the usage of herbs have been effective against diabetes because they have no adverse effects. Interestingly, South Africa, especially the Basotho tribe, is blessed with numerous medicinal plants whose usage in the treatment of DM has been effective since the conventional drugs are expensive and often unaffordable. The present study attempted to update the various scientific evidence on the twenty-three (23) plants originating from different parts of the world but widely used by the Sotho people in the management of DM. Asteraceae topped the list of sixteen (16) plant families and remained the most investigated according to this review. Although limited information was obtained on the antidiabetic activities of these plants, it is however anticipated that government parastatals and scientific communities will pay more attention to these plants in future research.

MAMayowa Agunbiade
Mayowa Agunbiade
Carolina PohlCarolina Pohl
Carolina Pohl
EHEsta Van Heerden
Esta Van Heerden
Oluwaseun Oyekanmi OyekolaOluwaseun Oyekanmi Oyekola
Oluwaseun Oyekanmi Oyekola
OAOmotayo Ashafa
Omotayo Ashafa
This study evaluated the potential of a biopolymeric flocculant produced by Terrabacter sp. isolated from Sterkfontein Dam, South Africa. Microbial flocculants aid the aggregation of suspended solutes in solutions, thus, suggesting its alternative application to inorganic and synthetic organic flocculants, which are associated with health-related problems. The 16S rDNA analysis revealed the bacteria to have 98% similarity to Terrabacter sp. MUSC78T and the sequence was deposited in the Genbank as Terrabacter sp. with accession number KF682157.1. A series of experimental parameters such as bioflocculant dosage, cations concentrations, pH, and application of the purified bioflocculant in wastewaters treatment were investigated. In the presence of glucose as a sole carbon source, Ca2+ as cation at pH 8, the optimal flocculating activity attained was 85%. Optimum bioflocculant dosage of 0.5 mg/mL was able to remove chemical oxygen demand (COD), biological oxygen demand (BOD), suspended solids (SS), nitrate, and turbidity in dairy wastewater. In addition, the tested bioflocculant exhibited higher flocculating efficiency as compared to polyaluminum chloride, polyethylenime, and alum. Inductible coupled plasma optical emission spectroscopy (ICP-OES) analyses confirmed significant removal of 77.7% Fe, 74.8% Al, 61.9% Mn, and 57.6% Zn as representatives of heavy metals from treated dairy wastewater. Fourier transform infrared spectroscopy (FTIR) indicated the presence of carboxyl, hydroxyl, and amino groups in the purified bioflocculant which could be responsible for flocculation. Findings from this study showed the prospect of the studied bioflocculant as an alternative candidate in wastewater treatment and remediating of heavy metals.

1 January 2017 in Pharmacognosy Magazine
Verified
Journal Article
Open access
PDF file
OAOmotayo Ashafa
Omotayo Ashafa
MNMikhail Olugbemiro Nafiu
Mikhail Olugbemiro Nafiu
Context: Dianthus basuticus is a plant of South African origin with various acclaimed pharmaceutical potentials. Aims: This study explored the antioxidant and antidiabetic activities of saponin extract from D. basuticus in vitro. Materials and Methods: Antioxidant activity of saponin was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide (*NO)-free radical scavenging activity while antidiabetic potentials were measured by the α-amylase and α-glucosidase inhibitory activities of the saponin extract. Results: The results showed that the saponin extract, compared with quercetin, displayed better DPPH (IC50 = 6.95 mg/ml) and NO (IC50 = 3.31 mg/ml) radical scavenging capabilities. Similarly, the saponin extracts elicited stronger α-glucosidase (IC50 = 3.80 mg/ml) and moderate α-amylase (IC50 = 4.18 mg/ml) inhibitory activities as compared to acarbose. Saponin exhibited a competitive mode of inhibition on α-amylase with same maximum velocity (Vmax) of 0.0093 mM/min for saponin compared with control 0.0095 mM/min and different the Michaelis constant (Km) values of 2.6 × 10-6 mM and 2.1 × 10-5 mM, respectively, while for α-glucosidase, the inhibition was uncompetitive, Vmax of 0.027 mM/min compared with control 0.039 mM/min and Km values of 1.02 × 10-6 mM and 1.38 × 10-6 mM, respectively. The gas chromatography-mass spectrometric analysis revealed the presence of bioactive like β- and α-amyrin, 3-O-methyl-D-glucose, methyl commate, and olean-12-en-3-beta-ol. Conclusion: Overall, the data suggested that the saponin extract from D. basuticus has potentials as natural antioxidants and antidiabetics. Abbreviations used: DPPH: 2,2-diphenyl-1-picrylhydrazyl, Km: The Michaelis constant, Vmax: Maximum velocity, ROS: Reactive oxygen species, NIDDM: Non-insulin-dependent diabetes mellitus, UFS: University of the Free State, GC-MS: Gas chromatography-mass spectrometric, MS: Mass spectrometry, NIST: National Institute of Standards and Technology, DNS: 3,5-dinitrosalicylic acid, NO: Nitric oxide, RNS: Reactive nitrogen species, PNPG: p-Nitrophenyl-α-D-glucopyranoside.

1 January 2016 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
Fatai Oladunni BalogunFatai Oladunni Balogun
Fatai Oladunni Balogun
OAOmotayo Ashafa
Omotayo Ashafa
The present study evaluated the safety of aqueous root extract of Dicoma anomala (AQRED) through acute and subchronic toxicity studies. Single oral dose of AQRED at the concentration of 0, 5, 300, and 2000 mg/kg as well as 125, 250, and 500 mg/kg/day was administered to rats for 14‐day acute and 90‐day subchronic oral toxicity studies. The results revealed no mortalities or observed clinical signs of toxicity in all the rats during both investigation periods. In subchronic toxicity testing, administration of AQRED also did not cause any changes in body weight as well as food and water consumption patterns. The haematological parameters and blood chemistry revealed no significant difference (p > 0.05) between the treatment and the control except in platelet count, alkaline phosphatase, and sodium levels where there was a significant increase (p < 0.05), although there was also a significant reduction (p < 0.05) in alanine transaminase, aspartate transaminase, and creatinine when compared to control. However, these changes were not reflecting the results from histology. Conclusively, the obtained results suggested that the LD50 of AQRED is in excess of 2000 mg/kg and its oral administration for 90 days revealed that it is unlikely to be toxic, hence, safe.